Anti-Human MET 2 Aptamer(Cat#: CTMM-0124-RJ53)

This product is an aptamer which binds to Human MET 2 with an affinity of 1-50 nM.

Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Protein
Target MET 2
Alternative Names MET Proto-Oncogene, Receptor Tyrosine Kinase; Hepatocyte Growth Factor Receptor; DFNB97; RCCP2; HGFR; Tyrosine-Protein Kinase Met; Scatter Factor Receptor; Proto-Oncogene C-Met; HGF/SF Receptor; HGF Receptor; SF Receptor; EC 2.7.10.1; Met Proto-Oncogene; EC 2.7.10; AUTS9; C-Met; DA11; MET 2
Gene ID 4233
UniProt ID P08581
Target Overview This gene encodes a member of the receptor tyrosine kinase family of proteins and the product of the proto-oncogene MET. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that are linked via disulfide bonds to form the mature receptor. Further processing of the beta subunit results in the formation of the M10 peptide, which has been shown to reduce lung fibrosis. Binding of its ligand, hepatocyte growth factor, induces dimerization and activation of the receptor, which plays a role in cellular survival, embryogenesis, and cellular migration and invasion. Mutations in this gene are associated with papillary renal cell carcinoma, hepatocellular carcinoma, and various head and neck cancers. Amplification and overexpression of this gene are also associated with multiple human cancers.
Chemical Modification 2'-ribo purines and 2'-fluoro pyrimidines
Type RNA
Species Reactivity Human
Length 50-100 nt
Affinity (Kd) 1-50 nM
Binding Conditions/Buffer DPBS
GC Content 48.84%
Molecular Weight 26112 g/mole
nmoles/OD260 1.096
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry